Scrip    Clinica    RAJ    Scrip Clinical Research    AnimalPharm
Email ID
Password
Forgotten your password?
Home
Therapy Sector
Generics
Business
Policy & Regulation
Research & Development
International
News
|
Comment
|
Features
|
Analysis
|
Supplements & Reports
|
People
|
Events
|
Multimedia
|
Science Abstracts
|
Pharma could hide adverse drug reaction reports under EU plans, NGOs say
08 February 2010
Eight organisations representing consumers, health insurers, healthcare professionals and NGOs are worried that the European Commission's draft legislative ...
Ex-BMS employee in US charged with trade-secret theft of SOPs
08 February 2010
US federal authorities have said that an ex-employee of Bristol-Myers Squibb in upstate New York has been arrested and charged with stealing trade secrets and ...
GSK to cut hundreds, not thousands of UK jobs
05 February 2010
GlaxoSmithKline is to expand its restructuring programme to deliver a further £500 million in pre-tax savings by 2012. The company plans to cease research into ...
US judge hears case challenging Myriad patents on BRCA cancer genes
04 February 2010
A US federal judge heard arguments on February 2nd in a lawsuit questioning the patentability of isolated human genes. However, it could be months before ...
 
Novartis licenses potential new hepatitis C treatment from Debiopharm
Today
Novartis has licensed exclusive rights to develop and market Debiopharm 's Debio 025 (alisporivir), which is currently in Phase IIb testing for the treatment of hepatitis C. Financial terms have not ...
Lupin gets US FDA approval for generic Lotrel
Today
Lupin has received final approval from the US FDA for amlodipine plus benazepril 2.5mg/10mg, 5mg/10mg, 5mg/20mg and 10mg/20mg capsules, generic versions of Novartis 's antihypertensive, Lotrel. ...
Pharmaxis completes Topigen acquisition as antifibrotic moves forward
Today
Pharmaxis has completed its acquisition of the private Canadian firm Topigen Pharmaceuticals in a move which expands its development portfolio in the respiratory area. The Australian company issued ...
US FDA approval for Strides' labetalol product
Today
Strides Arcolab has received US FDA approval for its ANDA for labetalol hydrochloride injection 100mg per 20ml and 200mg per 40 ml multi-dose vials, generic versions of Prometheus Laboratories ’ ...
 
Memantine filed for Alzheimer's disease in Japan
Today
Daiichi Sankyo 's Asubio Pharma subsidiary has submitted an approval application in Japan for memantine for the treatment of Alzheimer's disease. The NMDA receptor antagonist is licensed from Merz ...
Roche/Ipsen push taspoglutide filing back to 2011
08 February 2010
Roche / Ipsen have announced that they will file the GLP-1 analogue taspoglutide for type 2 diabetes in 2011, back from previous expectations that it would be filed in the fourth quarter of this ...
Takeda launches Mepact in EU for osteosarcoma
05 February 2010
Takeda Pharmaceuticals Europe has launched its anti-cancer Mepact (mifamurtide) in the EU for the treatment of adjuvant osteosarcoma (bone cancer). The drug is presently available via a paid ...
Daiichi Sankyo's edoxaban enters pivotal trial for VTE
04 February 2010
Daiichi Sankyo has begun recruiting for a key Phase III multinational clinical trial programme for its oral direct Factor Xa inhibitor, edoxaban. The pivotal HOKUSAI VTE study will compare the ...
 
Europe must prioritise science, Spain tells EU competitiveness meeting
Today
Europe needs to act now and adopt "concrete R&D measures" to prevent scientific research leaving the EU, Cristina Garmendia , Spain's science and innovation minister, has warned on behalf of the ...
Top Russian official sacked amid passing of new medicines law
Today
The Russian government has fired Nikolai Yurguel , the head of federal service on surveillance in healthcare and social development (Roszdravnadzor), saying that he has breached the law on civil ...
Ranbaxy's US facility gets FDA warning letter
08 February 2010
The US FDA 's recent warning letter to Ohm Laboratories over good manufacturing practice (GMP) deviations at its plant in Gloversville, New York, includes concerns over certain postmarketing and ...
US FDA prepares for biosimilars in 2011 budget plan, despite stalled reform bill
08 February 2010
As part of the unveiling of the Obama administration's fiscal year 2011 budget, FDA officials outlined how the agency plans to prepare for an approval pathway for follow-on biologics (or ...
 
PEOPLE
Arthur Higgins joins board at Resverlogix Arthur Higgins , CEO of Bayer HealthCare and chairman of the Bayer HealthCare executive committee, ...
New appointments at Onyx Pharmaceuticals Onyx Pharmaceuticals (US) has appointed Dr Ted Love executive vice-president and head of R&D. Dr ...
Biota appoints new director Biota Holdings (Australia) has appointed Professor Jeffery Errington non-executive director. ...
>> More People News...

EXPERT VIEW
Biotech funding is available - for companies with a clear plan
08 February 2010
Ian Schofield
2009 may have been a lean year for biotech firms, but things seem to be looking up and some small ...

Market Insight - Downturn leaves HIV/AIDS funds feeling the pinch
Today

The global economic crisis has had a significant negative impact on all areas of life, including ...

 Market Insight- The cost of donated drugs...
 Market Insight - Microdosing reaching a tippi...

Market Insight - Microdosing reaching a tipping point?
05 February 2010

Advocates of microdosing, a technique that involves testing very small doses of products in humans, ...

Market Insight - Originator/generic competition: who's the 'bad guy'?
28 January 2010

Intellectual property rights are key elements of the fierce competition between originator and ...

MULTIMEDIA
Scrip in a minute - week ending February 5th 05 February 2010

Get the Flash Player to see this player.

Comment: Is Bulgaria's decision to close hospitals premature?
04 February 2010
Maria Bailey
Bulgaria's government is close to implementing major changes to its national healthcare services to ...

European Medicines Agency and logos: snakes, DNA and the pestle and mortar
22 December 2009
Elizabeth Sukkar
Logos are said to be an important part of an organisation's branding. Really good logos contribute ...

Interview: European Medicines Agency gets serious about its global strategy
29 January 2010
Elizabeth Sukkar
Developing relationships with medicine regulators in China and India is just one of the challenges ...

CPhI Worldwide 2009
13 October 2009
Scrip's official preview of CPhI Worldwide, ICSE, P-MEC and BioPh 2009

Scrip's Stock Tracker: December 2009
12 January 2010
Ashley Yeo
In the equity markets, the investor wariness that was apparent during November continued into ...

EVENTS
10 February 2010
London, UK
11 February 2010
London, UK
23 February 2010
London, UK
JOB OF THE WEEK Promote your vacancy here
DIRECTORY Scrip Directory 2009
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36
Home
Therapy Sector
Generics
Business
Policy & Regulation
Research & Development
International
Terms & Conditions
Privacy Policy
Sitemap
About Us
Advertise
Subscribe
Scrip
Clinica
RAJ
Scrip Clinical Research
Animal Pharm